Скачать или смотреть TrichoTest: The First Genetic Test for Hair Loss

Fagron North America, a global leader in pharmaceutical compounding, debuts the most advanced genetic test supporting medical practitioners’ assessment and treatment of hair loss in the US: TrichoTest.* Today, TrichoTest is the only complete genetic test for alopecia and hereditary hair loss in the US market.

To receive more information on TrichoTest or Fagron Genomics, please visit: https://go.fagroncompanies.com/tricho...

About Fagron North America

Fagron North America (NA), a top-tier pharmaceutical supplier, is focused on creating the future of personalizing medicine through investments in genomics, technology, pharmacy essentials and 503B outsourcing.
Fagron Inc., a Fagron NA brand, produces high-quality, innovative pharmaceutical raw materials, equipment, and supplies to prepare personalized medication in the pharmacy. Fagron Inc. offers a broad product portfolio across oral and topical compounding ingredients. As a global leader in pharmaceutical compounding, Fagron supports patient-focused medication that works to improve quality of life.

*TrichoTest is not approved by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent disease. Any recommendations given to the requesting medical practitioner are for informational purposes only and no individual is required to use any products mentioned in a report.